FI62074C - Foerfarande foer framstaellning av nya farmakologiskt aktiva 5-fenyl-oxazolidinon-2-foereningar - Google Patents

Foerfarande foer framstaellning av nya farmakologiskt aktiva 5-fenyl-oxazolidinon-2-foereningar Download PDF

Info

Publication number
FI62074C
FI62074C FI762400A FI762400A FI62074C FI 62074 C FI62074 C FI 62074C FI 762400 A FI762400 A FI 762400A FI 762400 A FI762400 A FI 762400A FI 62074 C FI62074 C FI 62074C
Authority
FI
Finland
Prior art keywords
compound
phenyl
oxazolidinone
formula
methyl
Prior art date
Application number
FI762400A
Other languages
English (en)
Finnish (fi)
Other versions
FI762400A (fr
FI62074B (fi
Inventor
Friedrich-Gero Koellensperger
York Hartleben
Rolf Kretzschmar
Bernhard Neteler
Original Assignee
Nordmark Werke Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Werke Gmbh filed Critical Nordmark Werke Gmbh
Publication of FI762400A publication Critical patent/FI762400A/fi
Application granted granted Critical
Publication of FI62074B publication Critical patent/FI62074B/fi
Publication of FI62074C publication Critical patent/FI62074C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI762400A 1975-08-29 1976-08-20 Foerfarande foer framstaellning av nya farmakologiskt aktiva 5-fenyl-oxazolidinon-2-foereningar FI62074C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2538424 1975-08-29
DE2538424A DE2538424C2 (de) 1975-08-29 1975-08-29 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat

Publications (3)

Publication Number Publication Date
FI762400A FI762400A (fr) 1977-03-01
FI62074B FI62074B (fi) 1982-07-30
FI62074C true FI62074C (fi) 1982-11-10

Family

ID=5955093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762400A FI62074C (fi) 1975-08-29 1976-08-20 Foerfarande foer framstaellning av nya farmakologiskt aktiva 5-fenyl-oxazolidinon-2-foereningar

Country Status (22)

Country Link
US (1) US4139538A (fr)
JP (1) JPS5253857A (fr)
AT (1) AT347453B (fr)
AU (1) AU506441B2 (fr)
BE (1) BE845581A (fr)
CA (1) CA1072567A (fr)
CH (1) CH623043A5 (fr)
DE (1) DE2538424C2 (fr)
DK (1) DK387876A (fr)
FI (1) FI62074C (fr)
FR (1) FR2321884A1 (fr)
GB (1) GB1555658A (fr)
HU (1) HU174488B (fr)
IE (1) IE43396B1 (fr)
IL (1) IL50091A (fr)
IN (1) IN144061B (fr)
LU (1) LU75659A1 (fr)
NL (1) NL7609559A (fr)
NO (1) NO143316C (fr)
PL (1) PL100901B1 (fr)
SE (1) SE424991B (fr)
ZA (1) ZA764279B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179442A (en) * 1975-08-29 1979-12-18 York Hartleben 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
EP0008711B1 (fr) * 1978-08-15 1981-11-04 Smithkline Beckman Corporation Procédé de préparation de 2-hydroxy-3-isopropyl- ou de 2-hydroxy-3-tert-butylaminopropyl-éthers aromatiques
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
US5623087A (en) * 1995-03-10 1997-04-22 Ndsu-Research Foundation Method for preparation of optically active diarylalanines
GB9826700D0 (en) 1998-12-05 1999-01-27 Univ Durham Process for preparing chiral compounds
US20020019539A1 (en) 2000-03-31 2002-02-14 Bailey Anne E. Process for the preparation of matrix metalloproteinase inhibitors
WO2001074792A2 (fr) * 2000-03-31 2001-10-11 Abbott Laboratories Procede de preparation d'inhibiteurs de metalloproteinases matricielles
FR2832613B1 (fr) * 2001-11-27 2004-02-13 Seb Sa Panier de cuisson d'aliments pour autocuiseur, autocuiseur destne a recevoir un panier de cuisson et procede de fabrication d'un panier de cuisson d'aliments par emboutissage
JP2010503656A (ja) 2006-09-13 2010-02-04 アストラゼネカ アクチボラグ スピロ−オキサゾリジノン化合物と代謝共役型グルタミン酸受容体ポテンシエーターとしてのその使用
KR20150075091A (ko) * 2012-10-29 2015-07-02 에프. 호프만-라 로슈 아게 3,4-이치환된 옥사졸리디논 유도체 및 칼슘 활성화 칼륨 채널의 억제제로서 이의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302662B (fr) * 1971-02-04
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1157627B (de) * 1957-08-28 1963-11-21 Robins Co Inc A H Verfahren zur Herstellung von 5-(o-Alkoxyphenoxymethyl)-oxazolidonen-(2)
DE1130131B (de) * 1957-11-08 1962-05-24 Eugen Bellmann G M B H Maschf Bundkippzange
GB938424A (en) 1958-12-09 1963-10-02 American Cyanamid Co Improvements in or relating to substituted oxazolidin-2-ones
US3133932A (en) * 1959-05-25 1964-05-19 Deere & Co Production of 2-oxazolidinones
DE1198368B (de) * 1959-08-06 1965-08-12 Robins Co Inc A H Verfahren zur Herstellung von 5-(2, 6-Dimethoxyphenoxymethyl)-oxazolidon-(2)
DE1803180U (de) * 1959-11-05 1959-12-31 Wickmann Werke Ag Freiluft-isolator.
FR1274416A (fr) * 1959-12-09 1961-10-27 American Cyanamid Co Procédé de préparation de nouvelles aryloxyméthyl-2-oxazolidinones
US3450674A (en) * 1963-10-04 1969-06-17 Dow Chemical Co Poly-n-heterocyclics and method
GB1102011A (en) * 1964-05-21 1968-02-07 Richardson Merrell Spa Phenol esters of amino acids
NL129025C (fr) * 1965-04-29
US3538064A (en) * 1965-06-04 1970-11-03 Commercial Solvents Corp Acrylic acid esters of hydroxymethyl oxazolidones
GB1224995A (en) * 1968-09-20 1971-03-10 Delalande Sa New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE763964A (fr) * 1970-03-24 1971-09-08 Delalande Sa Nouveaux derives de l'aminocarbonyl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2179582B1 (fr) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
LU75659A1 (fr) 1977-03-31
IL50091A (en) 1981-01-30
AT347453B (de) 1978-12-27
PL100901B1 (pl) 1978-11-30
DE2538424C2 (de) 1983-01-05
AU1614576A (en) 1978-01-26
HU174488B (hu) 1980-01-28
FR2321884A1 (fr) 1977-03-25
IE43396B1 (en) 1981-02-11
FI762400A (fr) 1977-03-01
SE7609426L (sv) 1977-03-01
BE845581A (fr) 1976-12-16
NO762928L (fr) 1977-03-01
JPS5253857A (en) 1977-04-30
NO143316B (no) 1980-10-06
US4139538A (en) 1979-02-13
FR2321884B1 (fr) 1979-03-23
DK387876A (da) 1977-03-01
IN144061B (fr) 1978-03-18
SE424991B (sv) 1982-08-23
AU506441B2 (en) 1980-01-03
JPS564554B2 (fr) 1981-01-30
NL7609559A (nl) 1977-03-02
IL50091A0 (en) 1976-09-30
CA1072567A (fr) 1980-02-26
ZA764279B (en) 1977-07-27
ATA619876A (de) 1978-05-15
IE43396L (en) 1977-02-28
DE2538424A1 (de) 1977-03-03
NO143316C (no) 1981-01-14
FI62074B (fi) 1982-07-30
CH623043A5 (fr) 1981-05-15
GB1555658A (en) 1979-11-14

Similar Documents

Publication Publication Date Title
KR960016119B1 (ko) 히드록시메틸기 및 치환된 페닐기에 의해 치환된 신규의 이미다졸리딘, 이들의 제조방법, 의약으로서 이들의 용도, 이들을 함유하는 제약조성물 및 이들의 제조를 위한 중간체
CA2055859A1 (fr) Derives d'oxazolopyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FI62074C (fi) Foerfarande foer framstaellning av nya farmakologiskt aktiva 5-fenyl-oxazolidinon-2-foereningar
CA1057748A (fr) Piperazinyliminorifamycines
KR100894237B1 (ko) 항미생물제로서의엔-설포닐-4-메틸렌아미노-3-하이드록시-2-피리돈
EP0539281B1 (fr) Dérivés de naphtamides, leur procédé de préparation et leur application dans le domaine thérapeutique
FR2787451A1 (fr) Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2637596A1 (fr) Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant
EP0063084A1 (fr) Dérivés de phénéthanolamine, leur préparation et leur application en thérapeutique
CA2045849A1 (fr) Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0304353A1 (fr) Dérivés de benzimidazole et leur préparation
HU190710B (en) Process for preparing 2-/4-piperazinyl/-4-phenyl-quinazoline derivatives
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2687147A1 (fr) Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
EP0266246A1 (fr) Dérivés d'imidazo[4,5-b]pyridinone-2, leur préparation et leur application en thérapeutique
EP1569642A1 (fr) Utilisation de la canthin-6-one, des extraits de plantes la contenant et de ses derives dans le traitement des trypanosomiases
FR2649981A1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
JP3112356B2 (ja) シクロペンテノン化合物及び該化合物を有効成分とする脳機能改善薬
FR2692894A1 (fr) Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
US4544659A (en) Schistosomicidal acridanone hydrazones
EP0323303B1 (fr) Dérivés de nicotinoyl-pipérazine, procédé de préparation et utilisation en thérapeutique
WO2019018890A1 (fr) Nouveaux composés spirocycliques
EP0022407A1 (fr) Cyclophosphathiazènes, procédé pour leur préparation et compositions les contenant
EP0010030A1 (fr) Nouveaux dérivés d'ortho chloro benzoyl-2 chloro-4 glycylanilide, leur préparation et leur application en tant que médicaments

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NORDMARK-WERKE GESELLSCHAFT MIT